Where does Amir Zamani work?

Amir Zamani is Partner at Bain Capital Life Sciences and Board director at ViaCyte.

What does Amir Zamani invest in?

Amir Zamani invests in Biotech.

Where did Amir Zamani go to school?

Amir Zamani studied at Stanford University (Bachelor of Arts (B.A.), Bachelor of Science (B.S.)); The Johns Hopkins University School of Medicine (Doctor of Medicine (M.D.), Medicine); The London School of Economics and Political Science (LSE) (Economics).

Amir Zamani

Investor

Partner at Bain Capital Life Sciences · Board director at ViaCyte

Boston

Find your path to Amir

1,367 people in our graph share verified history with Amir — schools, employers, funds. One of them is your warm intro.

Laura BuhlerunlockedAmir: together at McKinsey & Company (2012)

×9Amir: together at McKinsey & Company

×2Amir: together at Bain Capital

About

Amir Zamani is a Partner on the Life Sciences team at Bain Capital, which he joined in 2018. He was previously a Partner at McKinsey & Company, where he worked in the Biopharmaceutical and Medical Products Practice, and earlier was a resident in Plastic Surgery at the University of Pennsylvania. He earned his MD from The Johns Hopkins University School of Medicine and holds a BS in biological sciences and a BA in economics from Stanford University.

Invests in

Biotech

Board director at ViaCyte

Intro paths

→

In turn, Amir can intro founders to ViaCyte's investors below.

ViaCyte's investors · 7

Artis VenturesSan Francisco · $50K – $25M checks Bain Capital Life SciencesBoston National Institutes of Health (NIH)since 2017 RA CapitalBoston Red Tree VentureSan Diego · since 2018 Sanderling VenturesSan Mateo · $50K – $1M checks The Vertical GroupBerkeley Heights · $250K – $5M checks

Experience

Bain CapitalPartner (Life Sciences Fund)current2018 — presentGreater Boston
McKinsey & CompanyPartner (Life Sciences Practice)2012 — 2018New York City Metropolitan Area
Penn Medicine, University of Pennsylvania Health SystemResident Physician (Plastic & Reconstructive Surgery)2008 — 2012Philadelphia

Skills & more

Languages English · Persian (Farsi) · Spanish

Medical License — Pennsylvania State Board of Medicine

From Amir's professional profile.

Colleagues at Bain Capital Life Sciences

Adam Fogel

Vice President at Bain Capital Credit

Adam M. Koppel

Managing Director at Bain Capital Life Sciences

Alexander Evans

Partner at Bain Capital Crypto

Alyson Goff

Associate at Bain Capital Life Sciences

Amarilice Young

Associate General Counsel at Bain Capital Life Sciences

Andrew Carlino

Partner at Bain Capital Credit

Andrew Hack

Partner at Bain Capital Life Sciences

Benjamin Nye

Managing Partner at Venture Guides Management, L.P.

Frequently asked questions

Who is Amir Zamani?: Amir Zamani is a Partner on the Life Sciences team at Bain Capital, which he joined in 2018. He was previously a Partner at McKinsey & Company, where he worked in the Biopharmaceutical and Medical Products Practice, and earlier was a resident in Plastic Surgery at the University of Pennsylvania. He earned his MD from The Johns Hopkins University School of Medicine and holds a BS in biological sciences and a BA in economics from Stanford University.
Where does Amir Zamani work?: Amir Zamani is Partner at Bain Capital Life Sciences and Board director at ViaCyte.
What does Amir Zamani invest in?: Amir Zamani invests in Biotech.
Where did Amir Zamani go to school?: Amir Zamani studied at Stanford University (Bachelor of Arts (B.A.), Bachelor of Science (B.S.)); The Johns Hopkins University School of Medicine (Doctor of Medicine (M.D.), Medicine); The London School of Economics and Political Science (LSE) (Economics).

Same school

Also attended Stanford University2,000

Peter ThielCo-founder & Partner at Founders Fund David SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto Czar Garry TanPresident & CEO of Y Combinator Alfred LinPartner at Sequoia Capital Jim BreyerFounder & CEO of Breyer Capital Mike Maples JrCo-founding Partner at Floodgate

+ 1,994 more

Also attended The Johns Hopkins University School of Medicine80

Hal PazInvestor at Khosla Ventures Rochelle WalenskyExecutive Partner at Flare Capital Partners Beth SeidenbergFounding Managing Director at Westlake Village BioPartners Stephen P. ZacharyManaging Partner at Sands Capital Ventures S.K. LeeExecutive Coach at Roble Ventures Eric HsuAnalyst, Private Equity at Sofinnova Ventures

+ 74 more

Also attended The London School of Economics and Political Science (LSE)1,642

Lee FixelFounder of Addition Pat GradyPartner at Sequoia Capital Neil MehtaCo-founder & Managing Partner at Greenoaks Cyriac ParisotInvestor at Index Ventures Sofia DolfeInvestor at Index Ventures Jonas VetterleInvestor at Moonfire Ventures

+ 1,636 more

Also attended Gilman School18

Jason FrankelPartner at Mainsail Partners Kevin RobbinsGeneral Partner at Blue Delta Capital Jeff SeibertExecutive Assistant at McKesson Ventures Robb DoubCo-Founder and General Partner at New Markets Venture Partners Sasank CharyPartner at Sageview Capital Lawson DeVriesManaging General Partner at Grotech Ventures

+ 12 more

Shared employers

Also worked at McKinsey & Company2,000

Ann Miura-KoCo-founding Partner at Floodgate Jeremy LiewPartner at Lightspeed Venture Partners Mike SpeiserManaging Director at Sutter Hill Ventures Jeremy LevinePartner at Bessemer Venture Partners Fabrice GrindaCo-founder & Managing Partner at FJ Labs Jeppe RindomCo-founder & CEO of Pleo

+ 1,994 more

Also worked at Penn Medicine, University of Pennsylvania Health System30

Jun JeonInvestor at Khosla Ventures Kingsley R. ChinManaging Partner at KIC Ventures Mark WasuwanichInvestor at Open Core Ventures Adam DakinHealthtech Advisor at Dreamit Ventures Kristin H WilsonInvestor at Rising Tide Africa (RTA)J.C. LopezPrincipal at New Enterprise Associates (NEA)

+ 24 more